PainChek

PainChek FCF/Net Income

The Free Cash Flow to Net Income Ratio of PainChek (PCK.AX) as of Oct 29, 2026 is 103.56 %. In the previous year, Free Cash Flow to Net Income Ratio was 88.18 % — a change of 17.44% (higher).

FCF/Net Income

103.56 %

YoY

17.44%

Last updated:

Free Cash Flow to Net Income Ratio of PainChek is 2026 103.56 % . Free Cash Flow to Net Income Ratio of PainChek was 2025 88.18 % . It decreases by 17.44% higher compared to the previous year.

The PainChek FCF/Net Income history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Net Income
Date
FCF/Net Income
Jan 1, 2019
94.70 AUD
Jan 1, 2020
15.59 AUD
Jan 1, 2021
68.95 AUD
Jan 1, 2022
122.71 AUD
Jan 1, 2023
83.65 AUD
Jan 1, 2024
86.20 AUD
Jan 1, 2025
88.18 AUD
Jan 1, 2026
103.56 AUD
The PainChek FCF/Net Income history
YEARFCF/Net IncomeYoY
103.56 %+17.44%
88.18 %+2.30%
86.20 %+3.05%
83.65 %-31.83%
122.71 %+77.96%
68.95 %+342.24%
15.59 %-83.53%
94.70 %+56.07%
60.68 %+224.65%
18.69 %-61.80%
48.92 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PainChek Stock analysis

What does PainChek do? PainChek Ltd. develops and commercializes mobile medical device applications, focusing on pain assessment for individuals unable to communicate with carers. The PainChek Universal combines the PainChek Application with the numerical rating scale (NRS), using artificial intelligence and facial recognition to detect pain in non-verbal patients. It provides a point-of-care solution that offers objectivity and consistency in pain assessments, supporting both non-verbal and self-reporting individuals through integrated tools. Healthcare providers and care facilities purchase PainChek Universal to enhance pain management protocols for patients with communication difficulties. The PainChek Application utilizes artificial intelligence and facial recognition technology to assess pain without relying on patient self-reporting, making it suitable for those with cognitive or physical impairments. PainChek Universal integrates the NRS for patients who can self-report, ensuring a comprehensive approach to pain evaluation across varying patient capabilities. This dual functionality allows healthcare professionals to apply consistent assessment standards regardless of a patient's ability to communicate. PainChek Ltd. generates revenue through the commercialization of its mobile medical device applications, specifically targeting healthcare providers and care facilities that require standardized pain assessment tools. The company’s products are designed to address the needs of patients who cannot communicate pain, thereby filling a critical gap in healthcare services. By offering a unified solution that combines AI-driven detection with traditional rating scales, PainChek Universal meets the demands of modern healthcare environments seeking objective and reliable pain management solutions. PainChek is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PainChek stock

Free Cash Flow to Net Income Ratio of PainChek is 103.56 % in 2026.

Free Cash Flow to Net Income Ratio of PainChek changed from 88.18 % to 103.56 %, representing a 17.44% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Net Income Ratio PainChek since 2006 – with annual values, charts, and detailed analysis.

The FCF/Net Income ratio measures cash flow quality. Ratios consistently above 100% suggest high-quality earnings with strong cash backing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Net Income Ratio's PainChek with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow to Net Income Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow to Net Income Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — PainChek

All Key Metrics — PainChek